Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust Study
Background and study aims : Large international clinical trials conducted in the past 5 years rapidly improved the treatment of chronic hepatitis C; however, it is unclear whether the advances seen in clinical trials are being paralleled by similar improvements in routine clinical practice. PegIntrust is a Belgian community-based trial evaluating the sustained virological response. Patients and Methods : Observational study of 219 patients receiving pegylated interferon alfa-2b (1.5 mu g/kg/wk) and weight. based ribavirin (800-1200 mg/day) for 48 weeks. Primary study end point was sustained vi... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | journalarticle |
Erscheinungsdatum: | 2010 |
Schlagwörter: | Medicine and Health Sciences / hepatitis C virus / community-based / pegylated interferon alfa-2b / ribavirin / tolerability / treatment / SVR / ALPHA-2B PLUS RIBAVIRIN / VIROLOGICAL RESPONSE / BELGIUM / THERAPY |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26981339 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://biblio.ugent.be/publication/1002280 |